Credit Analysis: ABLE2 UK LIMITED

1. Credit Opinion: CONDITIONAL

The credit opinion is CONDITIONAL. While the company presents a reasonable equity position with net assets of £3.4m, there are significant concerns that warrant caution and mitigating conditions on any facility.

Key concerns driving the conditional rating: - Near-zero cash reserves: Cash has collapsed from £1.79m (2017) to £729 (2024), leaving virtually no liquidity buffer - Loss-making in 2024: Retained earnings fell by £134,828, indicating the company operated at a loss - Working capital concentration: £3.55m tied up in debtors (81% of current assets) raises collection risk concerns - Stock build-up: Inventory increased 33% year-on-year while the business was loss-making, suggesting potential slow-moving stock

Positive factors supporting conditional (rather than decline): - Solid net asset base of £3.4m provides equity cushion - Net current assets remain positive at £2.9m - Long-term liabilities declining (from £543k to £444k) - 21-year trading history with established market position in medical equipment manufacturing - No overdue filings; compliant with statutory obligations

2. Financial Strength

Balance Sheet Summary (2024 vs 2023)

Capital Structure

The balance sheet shows a reasonable gearing position. Total liabilities (£1.49m) against net assets (£3.4m) yields a debt-to-equity ratio of approximately 0.44x, which is moderate. However, the composition of the balance sheet is concerning:

• Fixed assets (£943,789) represent only 18% of total assets, with £257,518 being investments in subsidiaries (illiquid)
• Current assets (£4.4m) dominate at 82% of total assets, but are overwhelmingly concentrated in debtors and stock
• Intangible assets decreased from £133,269 to £72,429, reflecting goodwill amortisation

Equity Trajectory

Net assets have grown substantially from £925k in 2016 to £3.4m in 2024, demonstrating long-term value creation. However, the trajectory has flattened and now reversed: - 2019: £3,068,529 - 2020: £3,199,240 - 2021: £3,384,640 - 2022: £3,417,447 - 2023: £3,531,574 - 2024: £3,396,746 (decline)

The 2024 decline of £134,828 in retained earnings signals a loss year, breaking the growth trend.

Capital Reserves

The called-up share capital of £1.76m is substantial, suggesting the business has been capitalised through equity rather than debt. This is positive from a creditor perspective.

3. Cash Flow Assessment

Cash Position - Critical Concern

The cash trajectory is alarming. From a healthy £1.79m in 2017, the company has systematically depleted its cash reserves to a negligible £729. The massive drop in 2019 (from £1.69m to £147k) warrants investigation - this may have involved a dividend extraction, intercompany transfer, or debt repayment to the parent.

Working Capital Analysis

While the current ratio of 2.95x appears healthy, it masks significant liquidity risk:

• Debtors represent 81% of current assets (£3.55m of £4.4m). If debtor collection extends or defaults occur, the company has virtually no cash to fall back on.
• Stock increased 33% from £634k to £845k while the company was loss-making, raising questions about inventory management and potential obsolescence in a medical equipment business.
• Current liabilities increased 16.5% from £1.28m to £1.49m, suggesting pressure on supplier payment terms.

Cash Conversion Cycle Concerns

The combination of high debtors, rising stock, and near-zero cash suggests the company may be experiencing working capital stress. The business appears to be selling on credit (high debtors) but struggling to convert those sales into cash. This pattern is common in companies extending credit terms to maintain revenue while experiencing collection difficulties.

Provisions

A new provision of £13,599 has been recognised in 2024 (nil in 2023). While small, this may signal emerging liabilities or restructuring costs.

4. Monitoring Points

Immediate Priority

1. Cash Management: The £729 cash position is unsustainable. Monitor whether this reflects year-end timing or a structural cash deficit. Request 13-month cash flow projections and bank statements.

2. Debtor Quality and Ageing: With £3.55m in debtors and negligible cash, understanding debtor quality is critical. Request an aged debtor report and assess days sales outstanding (DSO). Any significant debtor default would immediately threaten solvency.

3. Loss Investigation: The 2024 loss of ~£135k requires explanation. Is this a one-off event (e.g., write-offs, restructuring) or indicative of deteriorating trading conditions?

4. Intercompany Positions: The company has investments in subsidiaries (£257,518) and is owned by ADL Holdings Limited. Request details of all intercompany balances, guarantees, and cash extraction arrangements. The 2019 cash drop from £1.69m to £147k may indicate upstream cash transfers to the parent.

Ongoing Monitoring

5. Stock Composition: The 33% increase in stock during a loss-making year requires scrutiny. Request stock breakdown and assess obsolescence risk, particularly for medical equipment which may have regulatory expiry dates.

6. Creditor Payment Trends: Current liabilities increased 16.5%. Monitor whether this reflects normal trade creditor growth or indicates the company is stretching supplier payments to preserve cash.

7. Parent Company Support: Given ADL Holdings Limited controls 75%+ of shares, understand the parent's financial position and willingness/ability to provide financial support if needed.

8. Provisions: Monitor the new £13,599 provision and any further provisions that may indicate emerging liabilities.

9. Trading Performance: The income statement is not filed (permitted under small company regime), making profitability assessment difficult. Request management accounts to track monthly trading performance.

10. Sector Risks: Medical equipment manufacturing (SIC 26600) faces regulatory compliance costs, NHS procurement cycles, and potential exposure to government healthcare spending constraints.

Covenant Recommendations

If a facility is extended, consider including: - Minimum cash covenant (e.g., £50k minimum) - Maximum debtor days covenant - Restriction on upstream cash transfers to parent without lender consent - Financial information undertakings requiring quarterly management accounts - Parent company guarantee (given ADL Holdings' controlling interest)